Higher Contact-force Values Associated with Better Mid-term Outcome of Paroxysmal Atrial Fibrillation Ablation Using the SmartTouch™ Catheter
Overview
Physiology
Authors
Affiliations
Aims: Real-time measurement of contact force (CF) during catheter ablation of atrial fibrillation (AF) has been recently suggested to potentially impact procedural outcome. However, the role of CF intensity on mid-term results using the SmartTouch™ catheter has not been investigated so far.
Methods And Results: Pulmonary vein isolation (PVI) using the SmartTouch™ catheter was performed in 100 eligible patients (age 62 ± 8; 79% men) undergoing a first procedure of paroxysmal AF catheter ablation. Continuous CF monitoring during catheter ablation allowed calculation of mean CF per patient. Patients were dichotomized into high CF (≥22 g, upper quartile) and low CF (<22 g, remaining) and enroled in a standardized follow-up programme (after a 3-month blanking period), free from antiarrhythmic therapy, with regular evaluations including 24 h Holter recordings at 1, 3, 6, 9, 12, 18, and 24 months. Atrial fibrillation relapse was defined as any symptomatic or asymptomatic atrial arrhythmia lasting >30 s. The average CF among all procedures was 19.6 ± 3.7 g. Though complete PVI was eventually achieved in all cases in both groups, success using an exclusively anatomical approach was higher in the high CF group (92.0 vs. 72.0%; P = 0.04). During a mean follow-up of 19 ± 5 months, a lower incidence of AF relapse was observed in higher CF patients (4.0 vs. 20.0%; log rank P = 0.04). Pericardial tamponade occurred in one patient in the higher CF group. No thromboembolism or procedure-associated deaths were observed.
Conclusion: Higher values of CF overall during antral PVI appear to be associated with a higher likelihood of sinus rhythm maintenance without significantly increasing the complication rate.
Oh E, Shim J, Jeon S, Cho E, Lee S, Jeong T PLoS One. 2025; 20(1):e0302952.
PMID: 39836668 PMC: 11750084. DOI: 10.1371/journal.pone.0302952.
Fitzpatrick N, Herczeg S, Hong K, Seaver F, Rosalejos L, Boles U Front Cardiovasc Med. 2024; 10:1332868.
PMID: 38292455 PMC: 10825003. DOI: 10.3389/fcvm.2023.1332868.
Bortone A, Ramirez F, Constantin M, Bortone C, Hebert C, Constantin J Europace. 2023; 25(11).
PMID: 37851513 PMC: 10629717. DOI: 10.1093/europace/euad310.
Chen C, Lee P, Van Ba V, Chuang C, Lin Y, Lo L BMC Cardiovasc Disord. 2021; 21(1):387.
PMID: 34372779 PMC: 8353766. DOI: 10.1186/s12872-021-02196-y.
Hartley A, Shalhoub J, Ng F, Krahn A, Laksman Z, Andrade J Europace. 2021; 23(11):1698-1707.
PMID: 33948648 PMC: 8576280. DOI: 10.1093/europace/euab078.